ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Opinion

US can outshine China at coronavirus medical diplomacy

Washington needs to boost existing anti-pandemic research networks in Asia

| China
A medical staff takes samples at a drive-thru testing center in Daegu, South Korea, on Mar. 3; the U.S. can learn from its partners.   © Reuters

Erin Murphy is principal of Inle Advisory Group, a business advisory business focused on Myanmar and emerging Asian markets. She was special assistant to the U.S. Special Representative and Policy Coordinator for Burma.

The scramble to address the COVID-19 pandemic has opened a new power struggle between the U.S. and China, medical diplomacy.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more